 |
|
|
 |
|
| |
Borderline Personality Disorder:
Origins, Treatments, and Family
Perspectives
Saturday, May 7, 2005
Mary S. Harkness Auditorium, New Haven, CT
|
|
| |
Sponsored by:
|
The National Education Alliance
for Borderline Personality Disorder
(NEA-BPD) in
partnership with the National
Alliance for Research on
Schizophrenia and Depression
(NARSAD) |
|
| |
In
cooperation with:
|
Yale-New Haven Psychiatric
Hospital
Department of Psychiatry, Yale
University School of Medicine
The National Alliance for the
Mentally Ill-Connecticut |
|
| |
Conference
Objectives
|
At the conclusion of the
conference, attendees will be better
able to identify, specify, and
describe:
1. The symptomatology of BPD
2. The current understanding of
emotion dysregulation
3. The complexities of the
diagnostic issues surrounding BPD
4. Issues of concern to consumers
and family members
5. Research design elements and
outcomes of a family program
6. The problems and options of
medication programs for people with
BPD
7. Three psychosocial treatment
modalities |
|
| |
Course Description
|
The Conference is for physicians,
psychiatrists, psychologists, social
workers, family therapists,
counselors, nurses, emergency room
personnel, law enforcement personnel
and agencies, family members,
consumers, and educators.
Continuing Education credits for
social workers and Certificates of
Attendance are also available upon
request. |
|
| |
Statement of Need
|
Borderline Personality Disorder
(BPD) is a severe and generally
chronic disorder and people who
suffer from it are underserved.
Friends and families are often
bewildered and do not know how to
help. Treatment programs for those
with BPD need to be more readily
available. Families need access to
programs such as those already
developed for several other mental
illnesses. BPD presents patients,
their families and researchers with
multiple challenges. These complex
challenges will be addressed in
order to inform mental health
professionals, families, and
consumers of the most current
diagnostic and treatment options
available, and other issues of
current interest to those affected
by the disorder.
|
|
| |
|
|
|
| |
|
|
| |
Conference Program |
|
| |
Moderator for the day: Seth R.
Axelrod, PhD |
|
| |
|
|
| |
Welcome |
Perry D. Hoffman, PhD
The Mount Sinai School of Medicine
President, NEA-BPD
Seth R. Axelrod, PhD
Assistant Professor of Psychiatry
Intensive Outpatient Program
DBT/DBT-S Team Leader
Yale-New Haven Psychiatric Hospital
Yale University School of Medicine
|
|
| |
Opening Remarks
|
Benjamin S. Bunney, MD
Charles B.G. Murphy Professor and
Chairman of Psychiatry
Professor of Pharmacology
Yale University School of Medicine |
|
| |
Borderline Personality Disorder:
What Is It? |
Robert Stern, MD, PhD
Associate Clinical Professor of
Psychiatry
Yale University School of Medicine |
|
| |
Biopsychology of Emotion
Dysregulation |
Rajita Sinha, PhD
Associate Professor of Psychiatry
Director, Research Program on
Stress, Addiction and
Psychopathology
Director, Addiction Services
Connecticut Mental Health Center
Yale University School of Medicine |
|
| |
Disclosing the BPD Diagnosis:
Practice and Recommendations
|
Richard G. Hersh, MD
Assistant Clinical Professor of
Psychiatry
Columbia University College of
Physicians and Surgeons
Assistant Director of the Intensive
Outpatient Program
Columbia Presbyterian Medical Center |
|
| |
Family and Consumer Perspectives
Panel, and Family Research |
Dixianne Penney, Dr.PH
Executive Vice-President, NEA-BPD
Administrative Director
Center for the Study of Issues in
Public Health
Nathan Kline Institute for
Psychiatric Research
Perry D. Hoffman, PhD
Ellie Buteau, PhD |
|
| |
Psychopharmacology of BPD: Benefits
and Limitations |
Kenneth R. Silk, MD
Professor and Associate Chair
Clinical and Administrative Affairs
Department of Psychiatry
University of Michigan Health System |
|
| |
Transference-Focused Psychotherapy
|
Frank E.Yeomans, MD, PhD
Director of Training
Personality Disorders Institute
Clinical Associate Professor of
Psychiatry
Weill School of Medicine at Cornell
University |
|
| |
Dialectical Behavior Therapy |
George H. Davis, PhD
Clinical Director
Center for Dialectical and Cognitive
Behavioral Therapies
Assistant Clinical Professor of
Psychiatry
Yale University School of Medicine |
|
| |
Schema-Focused Therapy |
Samuel A. Ball, PhD
Associate Professor of Psychiatry
Director of Training, NIDA Clinical
Trials Network (New England Node)
Director of Residential Services,
APT Foundation
Yale University School of Medicine
Veterans Administration Connecticut
Healthcare |
|
| |
Treatment
Panel: Question and Answer Time
|
|
|
|
|
| |
 |
|
|
|
|
|
|
|
|